Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMEFF Appreciated Media		$0.00	$0.01 ▼ $0.05	N/A	N/A	63,600 shs	37,900 shs
BYI Bally Technologies		$0.00	$56.50 ▼ $84.66	N/A	N/A	839,983 shs	N/A
CEVMF CTS Eventim AG & Co. KGaA	$125.65	$118.46	$83.04 ▼ $125.65	N/A	N/A	217 shs	N/A
CHND China Media	$0.02	$0.64	$0.08 ▼ $37.00	N/A	N/A	425 shs	N/A
GILD Gilead Sciences	$111.78 +0.0%	$107.12	$66.34 ▼ $119.96	$139.01B	0.29	7.70 million shs	6.96 million shs

20 High-Yield Dividend Stocks that Could Ruin Your Retirement

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMEFF Appreciated Media	0.00%	0.00%	0.00%	0.00%	0.00%
CEVMF CTS Eventim AG & Co. KGaA	0.00%	0.00%	0.00%	+13.30%	+50.74%
CHND China Media	0.00%	0.00%	0.00%	0.00%	-98.00%
GILD Gilead Sciences	0.00%	+0.55%	-1.05%	+5.45%	+66.85%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMEFF Appreciated Media	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
BYI Bally Technologies	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CEVMF CTS Eventim AG & Co. KGaA	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
CHND China Media	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GILD Gilead Sciences	4.8347 of 5 stars	1.4	3.0	4.2	4.1	4.0	2.5	3.1

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMEFF Appreciated Media	0.00	N/A	N/A	N/A
BYI Bally Technologies	0.00	N/A	N/A	N/A
CEVMF CTS Eventim AG & Co. KGaA	0.00	N/A	N/A	N/A
CHND China Media	0.00	N/A	N/A	N/A
GILD Gilead Sciences	2.78	Moderate Buy	$110.55	-1.10% Downside

Current Analyst Ratings Breakdown

Latest GILD, AMEFF, BYI, CHND, and CEVMF Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
5/21/2025	GILD Gilead Sciences	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
4/25/2025	GILD Gilead Sciences	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$130.00 ➝ $135.00
4/25/2025	GILD Gilead Sciences	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Outperform ➝ Outperform	$132.00 ➝ $125.00
4/25/2025	GILD Gilead Sciences	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold ➝ Hold
4/22/2025	GILD Gilead Sciences	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Overweight	$125.00

(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMEFF Appreciated Media	N/A	N/A	N/A	N/A	N/A	N/A
BYI Bally Technologies	N/A	N/A	N/A	N/A	N/A	N/A
CEVMF CTS Eventim AG & Co. KGaA	N/A	N/A	N/A	N/A	N/A	N/A
CHND China Media	N/A	N/A	N/A	N/A	N/A	N/A
GILD Gilead Sciences	$28.75B	4.84	$6.87 per share	16.27	$15.44 per share	7.24

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMEFF Appreciated Media	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
BYI Bally Technologies	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
CEVMF CTS Eventim AG & Co. KGaA	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	8/21/2025 (Estimated)
CHND China Media	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
GILD Gilead Sciences	$480M	$4.75	23.53	13.78	0.72	20.76%	51.93%	17.40%	8/6/2025 (Estimated)

Latest GILD, AMEFF, BYI, CHND, and CEVMF Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/24/2025	Q1 2025	GILD Gilead Sciences	$1.77	$1.81	+$0.04	$1.04	$6.77 billion	$6.67 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMEFF Appreciated Media	N/A	N/A	N/A	N/A	N/A
BYI Bally Technologies	N/A	N/A	N/A	N/A	N/A
CEVMF CTS Eventim AG & Co. KGaA	N/A	N/A	N/A	N/A	N/A
CHND China Media	N/A	N/A	N/A	N/A	N/A
GILD Gilead Sciences	$3.16	2.83%	N/A	66.53%	10 Years

Latest GILD, AMEFF, BYI, CHND, and CEVMF Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/22/2025	GILD Gilead Sciences	quarterly	$0.79	3%	6/13/2025	6/13/2025	6/27/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMEFF Appreciated Media	N/A	N/A	N/A
BYI Bally Technologies	N/A	N/A	N/A
CEVMF CTS Eventim AG & Co. KGaA	N/A	N/A	N/A
CHND China Media	N/A	N/A	N/A
GILD Gilead Sciences	1.16	1.37	1.23

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMEFF Appreciated Media	N/A
BYI Bally Technologies	N/A
CEVMF CTS Eventim AG & Co. KGaA	26.29%
CHND China Media	N/A
GILD Gilead Sciences	83.67%

Insider Ownership

Company	Insider Ownership
AMEFF Appreciated Media	N/A
BYI Bally Technologies	N/A
CEVMF CTS Eventim AG & Co. KGaA	N/A
CHND China Media	N/A
GILD Gilead Sciences	0.27%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMEFF Appreciated Media	N/A	N/A	N/A	Not Optionable
BYI Bally Technologies	N/A	N/A	N/A	Not Optionable
CEVMF CTS Eventim AG & Co. KGaA	3,836	N/A	N/A	Not Optionable
CHND China Media	4	N/A	N/A	Not Optionable
GILD Gilead Sciences	17,600	1.24 billion	1.24 billion	Optionable

GILD, AMEFF, BYI, CHND, and CEVMF Headlines

Recent News About These Companies

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

July 7 at 4:07 PM | prnewswire.com

China Universal Asset Management Co. Ltd. Has $19.21 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

July 7 at 8:50 AM | marketbeat.com

Crossmark Global Holdings Inc. Acquires 12,364 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

July 7 at 7:43 AM | marketbeat.com

Raleigh Capital Management Inc. Sells 11,048 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

July 7 at 6:47 AM | marketbeat.com

TD Private Client Wealth LLC Sells 8,280 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

July 7 at 6:29 AM | marketbeat.com

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Truist Financial Corp

July 7 at 5:18 AM | marketbeat.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

July 6 at 10:00 AM | globenewswire.com

Gilead Sciences, Inc. (NASDAQ:GILD) Shares Bought by Chilton Capital Management LLC

July 6 at 9:17 AM | marketbeat.com

Jackson Wealth Management LLC Invests $461,000 in Gilead Sciences, Inc. (NASDAQ:GILD)

July 6 at 8:08 AM | marketbeat.com

Gilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Increased by Concurrent Investment Advisors LLC

July 6 at 6:59 AM | marketbeat.com

Capital Investment Advisory Services LLC Cuts Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

July 6 at 6:31 AM | marketbeat.com

OneDigital Investment Advisors LLC Decreases Stock Position in Gilead Sciences, Inc. (NASDAQ:GILD)

July 6 at 5:46 AM | marketbeat.com

GILD - Gilead Sciences Inc Financials - Morningstar

July 5 at 8:55 AM | morningstar.comM

Generali Investments CEE investicni spolecnost a.s. Sells 6,982 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

July 5 at 8:09 AM | marketbeat.com

Impax Asset Management Group plc Sells 96,564 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

July 5 at 6:53 AM | marketbeat.com

Harel Insurance Investments & Financial Services Ltd. Acquires Shares of 3,971 Gilead Sciences, Inc. (NASDAQ:GILD)

July 5 at 6:29 AM | marketbeat.com

Aviance Capital Partners LLC Sells 15,684 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

July 5 at 5:57 AM | marketbeat.com

D.A. Davidson & CO. Sells 11,159 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

July 5 at 5:40 AM | marketbeat.com

Mutual Advisors LLC Decreases Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)

July 5 at 5:30 AM | marketbeat.com

Gilead Sciences’ Ongoing Study on TAF for Pediatric Hepatitis B: Market Implications

July 4 at 12:13 PM | tipranks.com

Gilead Sciences Advances in Solid Tumor Treatment: A Phase II Study Update

July 4 at 12:13 PM | tipranks.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

GILD, AMEFF, BYI, CHND, and CEVMF Company Descriptions

Appreciated Media OTCMKTS:AMEFF

Appreciated Media Holdings, Inc. is a worldwide film and television media production packager. It engages in producing independent films, made-for-television movies, and TV series for global B2B distribution. The company was founded by Kirk Edward Shaw, Tony Zhang, and Norman Tsui on October 1, 2014 and is headquartered in Hamilton, Canada.

Bally Technologies NYSE:BYI

Bally Technologies, Inc. (Bally) is a global gaming company, which designs, manufactures, operates, and distributes advanced technology-based gaming devices, systems, server-based solutions, custom mobile applications, and interactive applications. The Company also provides hardware, including spinning-reel and video gaming devices, specialty gaming devices, and wide-area progressive systems. The Company supports customers include land-based, riverboat, and Native American casinos, video lottery and central determination markets. The Company derives its revenue from sale of gaming devices and related equipment, parts and conversion kits; operation of linked progressive systems, video lottery and centrally determined systems, and the rental of gaming devices and content, and sale and support of specialized systems-based software, hardware and interactive products and related recurring maintenance revenue. In July 2014, Bally Technologies Inc acquired Dragonplay Ltd. (Dragonplay).

CTS Eventim AG & Co. KGaA OTCMKTS:CEVMF

$125.65 0.00 (0.00%)

As of 07/3/2025

CTS Eventim AG & Co. KGaA operates in the leisure events market in Germany, Italy, the United States, Switzerland, Austria, the United Kingdom, Sweden, Finland, Spain, Brazil, Denmark, the Netherlands, and internationally. The company operates through two segments, Ticketing and Live Entertainment. The Ticketing segment produces, sells, brokers, distributes, and markets tickets for concerts, festival, theatre, musicals, trade fairs, art, cinema, exhibitions, edutainment, sports, and other events. It markets event tickets through stationary and online distribution EVENTIM.Net; inhouse ticketing product for classical music and theatre through EVENTIM.Inhouse; sport ticketing products through EVENTIM.Tixx; and self-service products for promotors through EVENTIM.Light, as well as provides a solution for ticket sales and admission control through EVENTIM.Access. This segment also operates kinoheld software for cinema operators. The Live Entertainment segment plans, prepares, and performs tours, events, and festivals, including music events and concerts, as well as markets music productions. This segment is also involved in the operation of venues. The company was formerly known as CTS EVENTIM AG and changed its name to CTS Eventim AG & Co. KGaA in May 2014. CTS Eventim AG & Co. KGaA was founded in 1989 and is headquartered in Bremen, Germany.

China Media NASDAQ:CHND

China Media Inc., through its subsidiaries, produces and distributes films, television series, and documentaries in China. The company sells television series to regional and national television stations. It distributes its films and television series through direct sales channel. The company was formerly known as Protecwerx Inc. China Media Inc. was incorporated in 2007 and is based in Xi'an, China.

Gilead Sciences NASDAQ:GILD

$111.78 +0.03 (+0.03%)

Closing price 04:00 PM Eastern

Extended Trading

$112.24 +0.46 (+0.41%)

As of 07:56 PM Eastern

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time